CHI Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$458K Sell
2023
Q1
$2.13M Sell
2022
Q4
$2.03M Hold
2022
Q3
$1.95M Buy
2022
Q2
$2.19M Buy
2022
Q1
$2.79M Buy
2021
Q4
$964K Buy
2021
Q3
$803K Sell
2021
Q2
$1.92M Buy
2021
Q1
$2.09M Buy
2020
Q4
$1.75M Sell
2020
Q3
$2.34M Buy
2020
Q2
$990K Hold
2020
Q1
$768K Sell
2019
Q4
$2.01M Sell
2019
Q3
$1.18M Buy